HER-2 B Cell Peptide Vaccine

Clinical trial NCT06414733 · RECRUITING

Trial details

NCT number: NCT06414733
Sponsor: Pravin T.P Kaumaya
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Metastatic Gastrointestinal Carcinoma HER2-positive Breast Cancer HER2-positive Gastric Cancer EGFR Overexpression

Start date: 2025-01-17
Primary completion: 2029-12-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.